Gene: FAM174B
Official Full Name: family with sequence similarity 174 member Bprovided by HGNC
Gene Summary: Involved in Golgi organization. Located in Golgi apparatus and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21433 | FAM174B Knockout cell line (HeLa) | Human | FAM174B | 1:3~1:6 | Negative | Online Inquiry |
KO21434 | FAM174B Knockout cell line (HEK293) | Human | FAM174B | 1:3~1:6 | Negative | Online Inquiry |
KO21435 | FAM174B Knockout cell line (A549) | Human | FAM174B | 1:3~1:4 | Negative | Online Inquiry |
FAM174B Gene Knockout Cell Lines are specially developed cellular models designed to facilitate the study of the FAM174B gene's function and its biological implications. This innovative product employs CRISPR-Cas9 gene-editing technology to create precise deletions in the FAM174B gene, enabling researchers to analyze the resultant phenotypes and molecular pathways influenced by this gene. The knockout cell lines provide a powerful platform for exploring gene function, studying gene-gene interactions, and understanding the roles of FAM174B in various cellular contexts.
The primary mechanism of action involves the targeted disruption of the FAM174B gene, which is hypothesized to play a role in immune response pathways. By erasing this gene, researchers can observe alterations in cell behavior, including changes in proliferation, differentiation, and metabolic processes. Such investigations are crucial for elucidating the gene's role in disease contexts, including immunological disorders, where understanding the underlying mechanisms is essential for developing new therapeutic strategies.
From a scientific perspective, FAM174B Gene Knockout Cell Lines hold significant importance in both basic and translational research. Their application extends to drug discovery, genetic studies, and functional genomics, making them invaluable tools in both academic and pharmaceutical laboratories. Moreover, the ability to systematically investigate gene function can aid in identifying novel biomarkers for disease diagnosis or prognosis, making this product essential for researchers aiming to advance the fields of genetics and molecular biology.
Advantages of our FAM174B Gene Knockout Cell Lines include exceptional specificity afforded by the CRISPR technology, ensuring minimal off-target effects when compared to traditional gene-knockout techniques. Furthermore, these cell lines are rigorously validated for consistency and reproducibility, allowing for reliable experimental outcomes. Our product also aims to provide seamless integration into existing research workflows, with both adherent and suspension formats available, catering to diverse experimental setups.
By utilizing FAM174B Gene Knockout Cell Lines, researchers and clinicians can accelerate the pace of discovery and enhance their understanding of critical biological processes. Their potential implications range from uncovering gene functions to contributing to the design of innovative therapeutic approaches, making them a cornerstone for groundbreaking research.
Our company is recognized for its commitment to advancing scientific research through high-quality biological products. With a robust background in genomics and cellular biology, we strive to deliver specialized tools like the FAM174B Gene Knockout Cell Lines that meet the evolving needs of researchers and clinicians worldwide.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.